Home > M&A deals 2008 > Elanco Animal Health, Inc. acquires Posilac(R)
Divestiture · Medical Products · August 2008

Elanco Animal Health, Inc. acquires Posilac(R)

On August 20, 2008, Elanco Animal Health, Inc. acquired Posilac(R), a medical products company in United States, from Monsanto Co.

Deal at a glance

AnnouncedAugust 20, 2008 TypeDivestiture TargetPosilac(R) Buyer Elanco Animal Health, Inc. Seller Monsanto Co. SectorMedical Products LocationUnited States ValueNot disclosed

Target company

Posilac(R)
United States
Medical Productssector
1999founded
Activestatus
View the company profile →

Buyer

Company · 14 deals on record
  • 1st transaction in medical products
  • 1st transaction in United States
14deals, all time
2in this sector
2021latest

Seller

Company · 13 deals on record
13investments
1in this sector
2exits

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Seraplex, Inc.Same sector and country · Oct 2026
Riverpoint MedicalSame sector and country · Jun 2026
Aloe Care Health, Inc.Same sector and country · Apr 2026

Questions about this deal

Who acquired Posilac(R)?Elanco Animal Health, Inc. acquired Posilac(R) on August 20, 2008.

Who sold Posilac(R)?Monsanto Co. was the seller.

What type of deal was it?It was a divestiture in the medical products sector in 2008.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).